Digitek Recalled Due to Manufacturing Defect
On April 28, 2008, the FDA recalled all lots of the heart medication drug, Digitek (also known as Digoxin). Sold throughout the United States under the "Bertek" and "UDL" labels, the drug, prescribed to treat heart failure and irregular heartbeat (arrhythmia), was recalled due to manufacturing defects.
Actavis Totowa, LLC (formerly known as Amide Pharmaceutical, Inc.), manufactures Digitek for distributors Mylan Pharmaceuticals, Inc. and UDL Laboratories. All strengths of Digitek have been recalled due to the possibility that tablets with double the appropriate thickness may contain twice the approved level of active ingredient.
Recalled Medications Include:
- Digitek
- Digoxin
- Cardoxin
- Lanoxin
- Lanoxicaps
The Digitek recall has been classified as a Class I recall, meaning that the product poses a significant risk of serious injury or death. The double-strength tablets pose a risk of Digitalis Toxicity, which can be fatal for individuals with renal failure or impaired kidney function.
| Digititis Toxicity Symptoms Include: |
|
Nausea
Vomiting
Dizziness
Low Blood Pressure
Cardiac Instability
Fatigue
Bradycardia (Slow Heartbeat)
|
Yellow or Green Vision
Hallucinations
Decreased Appetite
Diarrhea
Confusion
Death
|
Pharmacies are currently contacting patients who may have received the double thickness pills. If you, a friend or family member took Digitek or one of it's generic equivalents and have suffered any adverse side effects, please contact us immediately. Your time to receive compensation for your injuries may be short. Contact us today for a free, private consultation.
CLICK HERE to contact us today, or send an email to Info@HelpingTheInjured.com
|
